| Members |
targetComponentId |
| Syringing - action |
Irrigation - action (qualifier value) |
| syringomyélobulbie |
Syringomyelia and syringobulbia |
| Other acquired deformity of finger, NEC |
Deformity of phalanx of finger or thumb |
| Systemic chondromalacia |
Relapsing polychondritis |
| Systemic inflammatory response syndrome associated with organ dysfunction |
Acute organ dysfunction due to systemic inflammatory response syndrome (disorder) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| Sézary's disease of extranodal AND/OR solid organ site |
Sézary's disease (disorder) |
| T-shaped fracture |
T-shaped fracture |
| T-zone lymphoma |
Peripheral T-cell lymphoma |
| T0 category |
American Joint Committee on Cancer cT0 (qualifier value) |
| T1 (I): Cervical carcinoma confined to uterus |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 (I): Endometrial tumor confined to corpus uteri |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 (I): Trophoblastic disease confined to uterus |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 (I): Tumor confined to vagina |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 (I): Tumor limited to fallopian tube(s) |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 (IA): Trophoblastic disease confined to uterus with no risk factors |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 (IB): Trophoblastic disease confined to uterus with one risk factor |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 (IC): Trophoblastic disease confined to uterus with two risk factors |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1 category |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Aerodigestive tract tumor < 2 cm in greatest dimension |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Aerodigestive tract tumor < 2 cm in greatest dimension without extraparenchymal extension |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Aerodigestive tract tumor confined to ethmoid with or without bone erosion |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Aerodigestive tract tumor confined to nasopharynx |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Breast tumor <= 2 cm in greatest dimension |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Clinically inapparent prostate tumor not palpable or visible by imaging |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Kidney tumor < 7.0 cm in greatest dimension limited to the kidney |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Lung tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Solitary liver tumor < 2 cm; no vascular invasion |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Testicular tumor limited to the testis and epididymis without vascular/lymphatic invasion (tumor may invade tunica albuginea but not tunica vaginalis) |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor invades lamina propria or submucosa |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor invades submucosa (colon/rectum) |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to ampulla of Vater or sphincter of Oddi |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to ipsilateral parietal and/or visceral pleura |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to one subsite of hypo-pharynx and < 2 cm in greatest dimension |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to pancreas and < 2 cm in greatest dimension |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to subglottis |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to the antral mucosa with no erosion or destruction of bone |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Tumor size < 1 cm, limited to thyroid |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1: Urinary tract tumor invades subepithelial connective tissue |
American Joint Committee on Cancer cT1 (qualifier value) |
| T1a (IA): Invasive carcinoma of uterine cervix diagnosed by microscopy only |
cT1a |
| T1a (IA): Tumor limited to endometrium |
cT1a |
| T1a (IA): Tumor limited to one fallopian tube without penetrating the serosal surface, no ascites |
cT1a |
| T1a (IA): Tumor limited to one ovary, capsule intact, no tumor on ovarian surface |
cT1a |
| T1a1 (IA1): Tumor of uterine cervix with stromal invasion < 3.0 mm in depth and horizontal spread < 7.0 mm |
American Joint Committee on Cancer cT1a1 (qualifier value) |
| T1a2 (IA2): Tumor of uterine cervix with stromal invasion > 3.0 mm but < 5.0 mm in depth and horizontal spread < 7.0 mm |
American Joint Committee on Cancer cT1a2 (qualifier value) |
| T1a: Breast tumor >0.1 cm but <= 0.5 cm in greatest dimension |
cT1a |
| T1a: Esophagus/stomach tumor invades lamina propria |
cT1a |
| T1a: Prostate tumor incidental histologic finding in 5 percent or less of tissue resected |
cT1a |
| T1a: Tumor limited to one vocal cord |
cT1a |
| T1b (IB): Endometrial tumor invades up to or less than one half of the endometrium |
cT1b |
| T1b (IB): Tumor limited to both ovaries: capsule intact, no tumor on ovarian surface |
cT1b |
| T1b (IB): Tumor limited to both tubes without penetrating the serosal surface: no ascites |
cT1b |
| T1b (IB): Tumor of uterine cervix with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 |
cT1b |
| T1b1 (IB1): Tumor of uterine cervix, clinically visible lesion < 4.0 mm in greatest dimension |
American Joint Committee on Cancer cT1b1 (qualifier value) |
| T1b2 (IB2): Tumor of uterine cervix, clinically visible lesion > 4.0 mm in greatest dimension |
American Joint Committee on Cancer cT1b2 (qualifier value) |
| T1b: Breast tumor >0.5 cm but <= 1 cm in greatest dimension |
cT1b |
| T1b: Esophagus/stomach tumor invades submucosa |
cT1b |
| T1b: Prostate tumor incidental histologic finding in greater than 5 percent of tissue resected |
cT1b |
| T1b: Tumor involves both vocal cords |
cT1b |
| T1c (IC): Endometrial tumor invades to more than one half of the endometrium |
American Joint Committee on Cancer cT1c (qualifier value) |
| T1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings: OVARY: Resection |
American Joint Committee on Cancer cT1c (qualifier value) |
| T1c (IC): Tumor limited to one or both tube(s) with extension into or through the tubal serosa; or with malignant cells in ascites or peritoneal washings: FALLOPIAN TUBE: Salpingectomy |
American Joint Committee on Cancer cT1c (qualifier value) |
| T1c: >1 cm but <= 2 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy |
American Joint Committee on Cancer cT1c (qualifier value) |
| T1c: Tumor identified by needle biopsy because of elevated prostate specific antigen: PROSTATE: Biopsy/transurethral resection: PROSTATE: Resection |
American Joint Committee on Cancer cT1c (qualifier value) |
| T1mic: Microinvasion <= 0.1 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy |
cT1mi |
| T2 (II): Endometrial tumor invades cervix, but does not extend beyond uterus |
cT2 |
| T2 (II): Fallopian tube tumor involves one or both tube(s) with pelvic extension |
cT2 |
| T2 (II): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but is limited to the genital structures (adnexa, vagina, broad ligament) |
cT2 |
| T2 (II): Tumor of uterine cervix invades beyond the uterus but not to pelvic wall or to lower third of vagina |
cT2 |
| T2 (II): Vaginal tumor invades paravaginal tissues but not to pelvic wall |
cT2 |
| T2 (IIA): Trophoblast: gestational trophoblastic tumor involving genital structure without risk factors |
cT2 |
| T2 (IIB): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with one risk factor |
cT2 |
| T2 (IIC): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with two risk factors |
cT2 |
| T2 category |
cT2 |
| T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension |
cT2 |
| T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension without extraparenchymal extension |
cT2 |
| T2: Aerodigestive tract tumor causing bone erosion or destruction, except for the posterior antral wall, including extension into hard palate and/or middle nasal meatus |
cT2 |
| T2: Aerodigestive tract tumor extends into nasal cavity |
cT2 |
| T2: Aerodigestive tract tumor extends to soft tissue of oropharynx and/or nasal fossa |
cT2 |
| T2: Aerodigestive tract tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility |
cT2 |
| T2: Aerodigestive tract tumor extends to vocal cord(s) with normal or impaired mobility |
cT2 |
| T2: Aerodigestive tract tumor invades more than one subsite of hypopharynx or an adjacent site, or measures > 2 cm but < 4 cm in greatest dimension, without fixation of hemilarynx |
cT2 |
| T2: Aerodigestive tract tumor invades mucosa of >1 adjacent subsite of supraglottis/glottis/region outside supraglottis, (mucosa of base of tongue/vallecula/medial wall of piriform sinus) without fixation of larynx |
cT2 |
| T2: Ampulla tumor invades duodenal wall |
cT2 |
| T2: Breast tumor > 2 cm but <= 5 cm in greatest dimension |
cT2 |
| T2: Ovarian tumor involves one or both ovaries with pelvic extension |
cT2 |
| T2: Pleural tumor invades any of the following: ipsilateral lung, endothoracic fascia, diaphragm, or pericardium |
cT2 |
| T2: Renal pelvis/ureter tumor invades the muscularis |
cT2 |
| T2: Renal tumor > 7.0 cm in greatest dimension limited to the kidney |
cT2 |
| T2: Stomach tumor invades muscularis propria or subserosa |
cT2 |
| T2: Testicular tumor limited to the testis and epididymis with vascular/lymphatic invasion or tumor extending through tunica albuginea with involvement of tunica vaginalis |
cT2 |
| T2: Tumor > 1 cm but < 4 cm, limited to thyroid |
cT2 |
| T2: Tumor confined within the prostate |
cT2 |
| T2: Tumor invades muscularis propria |
cT2 |
| T2: Tumor limited to pancreas and > 2 cm in greatest dimension |
cT2 |
| T2: Urinary bladder tumor invades muscle |
cT2 |
FHIR